(Reuters) - Chris Larson of San Diego filed a class-action lawsuit against MedImmune and its senior officers and directors, claiming the sale benefited them more than ordinary shareholders.
"This is a matter for MedImmune as AstraZeneca is not party to the suit. However, MedImmune's SEC filing states that it does not believe the suit has any merit. Therefore we are confident that the deal will go ahead," an AstraZeneca spokesman said.
Read more at Reuters.com Mergers News
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment